Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003
Question: Does adjuvant interferon alfa improve survival after resection of stage I, II, or III malignant melanoma?
Data Sources: Electronic searches of MEDLINE (1966-March 2001), EMBASE (1974-March 2001), and the Controlled Trials Register from the Cochrane Library (issue 4, 2000) using medical subject headings (MeSH) "melanoma" and "interferon alpha." Also, review articles, textbooks, conference proceedings, and discussions with experts in the field were used to identify other published or unpublished data.
Ready N, Weinstock MA. Adjuvant High-Dose Interferon Therapy for High-Risk Melanoma. Arch Dermatol. 2003;139(12):1635–1637. doi:10.1001/archderm.139.12.1635
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: